Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis

NCT00323960 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

139

Enrollment

OTHER

Sponsor class

Conditions

Juvenile Dermatomyositis

Interventions

DRUG: 3 MPDN pulse + PDN
DRUG: 3 MPDN pulse + PDN + CSA
DRUG: 3 MPDN pulse + PDN + MTX

Sponsor

Istituto Giannina Gaslini

Collaborators

[object Object]